The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination.
Raw material testing to account for the largest share of the bioburden testing applications market
Based on application, the bioburden testing market is segmented into raw material testing, medical device testing, in-process material testing, sterilization validation testing, and equipment cleaning validation. The raw material testing segment is expected to account for the largest market share in 2018. The large share of this segment can be attributed to the rising quality standards in manufacturing to avoid consequences such as contaminations and breakdown manufacturing process.
Bioburden testing consumables to dominate the market in 2018
Based on product, the bioburden testing market is segmented into consumables and instruments. By type, the market for consumables is segmented into culture media, reagents, and kits, and other consumables. The bioburden testing instruments market is further segmented into automated microbial identification systems, PCR instruments, microscopes, and other instruments. In 2018, the consumables segment is expected to account for the largest share of the bioburden testing market. The large share of this segment majorly attributed to the requirement of repeat purchase of kits and reagents, unlike instruments which are considered as a one-time investment. The long shelf life and the repeated purchase of media, kits, and reagents (as opposed to instruments which are considered as a one-time investment) are driving the adoption of bioburden testing consumables
Comments
Post a Comment